Isogenica, a provider of diagnostic peptides, proteins and antibodies, has established a new automation facility in Chesterford Research Park.
Subscribe to our email newsletter
The expansion helps CIS display platform for the discovery of biological therapeutics, diagnostics and reagents using Tecan liquid handling robots and screening equipment.
The development further brings additional capacity to the company for the selection of next generation molecules for biopharmaceutical projects with capacity of up to two hundred selections.
Isogenica CEO Kevin Matthews said their nvestment in this new facility is to accommodate recent increases in activity in their peptide/protein selection platform and to fulfill future demand from both industry and academia.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.